MedPath

Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal Calculus

Phase 3
Conditions
Renal Calculi
Interventions
Registration Number
NCT01215708
Lead Sponsor
University of Sao Paulo General Hospital
Brief Summary

The investigators objective is to study if some drugs can improve the success rate of extracorporeal shockwave lithotripsy for renal stones.

Detailed Description

Extracorporeal shockwave lithotripsy is one of the modalities of treatment of renal stones. It´s a machine that breaks the renal stones extracorporeally. Some drugs, like alpha blockers and calcium channel blockers, can improve the success rates of this procedure. Our objective is to study the real effects of two drugs, tamsulosin and nifedipine, compared to placebo, in the elimination of fragments after the extracorporeal shockwave lithotripsy treatment.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
136
Inclusion Criteria
  • radiopaque renal stone, 5 to 20 mm, located at renal pelvis or superior or middle calix
Exclusion Criteria
  • inferior calix, any contraindication for extracorporeal shockwave lithotripsy, pregnancy, coagulopathy, previous renal surgery, age under 18, abdominal aorta aneurism and urinary infection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NifedipineTamsulosinnifedipine retard 20mg daily
tamsulosinTamsulosintamsulosin 0,4mg
placeboTamsulosinplacebo capsule
Primary Outcome Measures
NameTimeMethod
To evaluate the effects of Tamsulosin and Nifedipine in the success rates after treatment of radiopaque renal stones between 5-20 mm with only one session of SWL30 days
Secondary Outcome Measures
NameTimeMethod
To evaluate the effects of Tamsulosin and Nifedipine in the episodes of pain after treatment of radiopaque renal stones between 5-20 mm with only one session of SWL30 days
To evaluate the effects of Tamsulosin and Nifedipine in the velocity of elimination of fragments after treatment of radiopaque renal stones between 5-20 mm with only one session of SWL30 days

Trial Locations

Locations (1)

Clinics Hospital of University of Sao Paulo

🇧🇷

Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath